140 related articles for article (PubMed ID: 20797775)
1. The role of restaging borderline ovarian tumors: single institution experience and review of the literature.
Zapardiel I; Rosenberg P; Peiretti M; Zanagnolo V; Sanguineti F; Aletti G; Landoni F; Bocciolone L; Colombo N; Maggioni A
Gynecol Oncol; 2010 Nov; 119(2):274-7. PubMed ID: 20797775
[TBL] [Abstract][Full Text] [Related]
2. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
[TBL] [Abstract][Full Text] [Related]
3. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours.
Querleu D; Papageorgiou T; Lambaudie E; Sonoda Y; Narducci F; LeBlanc E
BJOG; 2003 Feb; 110(2):201-4. PubMed ID: 12618166
[TBL] [Abstract][Full Text] [Related]
5. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
6. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
[TBL] [Abstract][Full Text] [Related]
7. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
8. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic restaging of borderline ovarian tumors.
Daraï E; Tulpin L; Prugnolle H; Cortez A; Dubernard G
Surg Endosc; 2007 Nov; 21(11):2039-43. PubMed ID: 17514402
[TBL] [Abstract][Full Text] [Related]
11. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
[TBL] [Abstract][Full Text] [Related]
12. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?
Cho YH; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2006 Dec; 103(3):878-82. PubMed ID: 16859736
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
[TBL] [Abstract][Full Text] [Related]
14. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors.
Desfeux P; Camatte S; Chatellier G; Blanc B; Querleu D; Lécuru F
Gynecol Oncol; 2005 Sep; 98(3):390-5. PubMed ID: 16043215
[TBL] [Abstract][Full Text] [Related]
15. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
[TBL] [Abstract][Full Text] [Related]
17. Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer.
Ramirez PT; Slomovitz BM; McQuinn L; Levenback C; Coleman RL
Gynecol Oncol; 2006 Dec; 103(3):888-90. PubMed ID: 16806436
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience.
Leblanc E; Querleu D; Narducci F; Occelli B; Papageorgiou T; Sonoda Y
Gynecol Oncol; 2004 Sep; 94(3):624-9. PubMed ID: 15350350
[TBL] [Abstract][Full Text] [Related]
19. Are borderline tumors of the ovary safely treated by laparoscopy?
Maneo A; Vignali M; Chiari S; Colombo A; Mangioni C; Landoni F
Gynecol Oncol; 2004 Aug; 94(2):387-92. PubMed ID: 15297177
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome.
Nezhat FR; Ezzati M; Chuang L; Shamshirsaz AA; Rahaman J; Gretz H
Am J Obstet Gynecol; 2009 Jan; 200(1):83.e1-6. PubMed ID: 19019337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
